Zhao Yang, Li Xiao, Zhu Siquan
Beijing Tongren Eye Center, Beijing Key Laboratory of Ophthalmology and Visual Science, Beijing Tongren Hospital, Capital Medical University, Beijing 100073, P.R. China.
Mol Med Rep. 2016 Sep;14(3):2305-10. doi: 10.3892/mmr.2016.5465. Epub 2016 Jul 4.
MicroRNAs (miRNAs) negatively regulate the expression of the target genes by binding to 'seed sequences' in the 3'‑untranslated region (3'‑UTR) mRNA transcripts, and the variants within or nearby 'seed sequences' may compromise or enhance miRNA/mRNA interaction leading to either 'loss‑of‑function' or 'gain‑of‑function' effects. Cataracts are the leading cause of blindness worldwide and are characterized by progressive aggregation and precipitation of lens proteins, and the development of age‑related cataracts is associated with dysregulated cellular activities of lens epithelial cells. Luciferase assays and online miRNA databases were used to validate that tumor protein p53 (TP53) is the target gene of miR‑125b. Furthermore, reverse transcription‑quantitative polymerase chain reaction and western blotting were conducted to detect expression levels of miR‑125b and TP53 in different groups of cells transfected with miR‑125b mimics or inhibitors. In addition, flow cytometry analysis and the MTT assay were conducted to detect the effects of miR‑125b on apoptosis and cell viability. The current study demonstrated that the rs78378222 polymorphism minor allele introduces a novel potential miR‑125b binding site in the TP53 3'‑UTR with a consecutive 8‑bp perfect match, creating a 'gain‑of‑function' variant and affecting the regulation of TP53 expression. A luciferase assay demonstrated that transfection of lens epithelial cells with wild type TP53 3'‑UTR significantly reduced the luciferase activity of the miR‑125b overexpressing cells compared with scramble controls. In addition, the luciferase activity of miR‑125b overexpressing cells transfected with the construct containing the rs78378222 polymorphism minor allele was also reduced compared with cells transfected with the wild type 3'‑UTR. Furthermore, it was demonstrated that the expression level of miR‑125 was comparable in epithelial cells from patients with age‑associated cataracts and controls, whereas the expression level of TP53 was significantly higher in the cataract group compared with controls. Additionally, transfection with 50 nM miR‑125b mimics markedly reduced the mRNA and protein expression levels of TP53 in the cultured lens epithelial cells, and miR‑125b significantly induced apoptosis in the epithelial cells compared with negative control cells. In conclusion, TP53 was identified as a target of miR‑125b, and the minor allele of the rs78378222 polymorphism promoted the miR-125b/TP53 mRNA interaction.
微小RNA(miRNA)通过与信使核糖核酸(mRNA)转录本3'非翻译区(3'-UTR)中的“种子序列”结合来负向调节靶基因的表达,“种子序列”内部或附近的变体可能会损害或增强miRNA/mRNA相互作用,从而导致“功能丧失”或“功能获得”效应。白内障是全球失明的主要原因,其特征是晶状体蛋白的渐进性聚集和沉淀,年龄相关性白内障的发生与晶状体上皮细胞的细胞活动失调有关。采用荧光素酶报告基因检测和在线miRNA数据库来验证肿瘤蛋白p53(TP53)是miR-125b的靶基因。此外,进行逆转录-定量聚合酶链反应和蛋白质免疫印迹法以检测用miR-125b模拟物或抑制剂转染的不同细胞组中miR-125b和TP53的表达水平。另外,进行流式细胞术分析和MTT检测以检测miR-125b对细胞凋亡和细胞活力的影响。当前研究表明,rs78378222多态性次要等位基因在TP53的3'-UTR中引入了一个新的潜在miR-125b结合位点,该位点与8个连续碱基对完全匹配,产生一个“功能获得”变体并影响TP53表达的调控。荧光素酶报告基因检测表明,与对照序列相比,用野生型TP53 3'-UTR转染晶状体上皮细胞可显著降低miR-125b过表达细胞的荧光素酶活性。此外,与用野生型3'-UTR转染的细胞相比,用含有rs78378222多态性次要等位基因的构建体转染的miR-125b过表达细胞的荧光素酶活性也降低。此外,研究表明,年龄相关性白内障患者和对照者的上皮细胞中miR-125的表达水平相当,而白内障组中TP53的表达水平与对照组相比显著更高。另外,用50 nM miR-125b模拟物转染可显著降低培养的晶状体上皮细胞中TP53的mRNA和蛋白表达水平,并且与阴性对照细胞相比,miR-125b可显著诱导上皮细胞凋亡。总之,TP53被鉴定为miR-125b的靶标,并且rs78378222多态性的次要等位基因促进了miR-125b/TP53 mRNA相互作用。